- Report
- April 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 115 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 124 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- August 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- June 2024
- 270 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 158 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- July 2024
- 156 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- May 2024
- 75 Pages
Global
From €9502EUR$9,995USD£7,982GBP
- Report
- January 2025
- 256 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 100 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2024
- 80 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- October 2024
- 70 Pages
Latin America
From €903EUR$950USD£759GBP
- Report
- January 2023
- 248 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- October 2023
- 159 Pages
Global
From €2139EUR$2,250USD£1,797GBP
€4278EUR$4,500USD£3,594GBP
- Report
- September 2022
- 291 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- September 2023
- 449 Pages
Global
From €4706EUR$4,950USD£3,953GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more